Harvard and Google to release 1 million public-domain books as AI training dataset | TechCrunch
AI training data has a big price tag, one best-suited for deep-pocketed tech firms. This is why Harvard University plans to release a dataset that
Related Articles
Physicists measure quantum geometry for first time
The Official Website of MIT Department of Physics
Telehealth and doctors win, PBMs lose as government funding deal nears
The last-minute agreement to keep government funded until March likely also includes hospital-at-home provisions and more.
Walmart employees are now wearing body cameras in some stores
Walmart store associates are now using body cameras in some locations as retailers look to deter theft and make employees safer.
BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine – Clinical Epigenetics
Background BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) encode for tumor suppressor proteins which are critical regulators of the Homologous Recombination…
Sanofi sues feds over moves to stop 340B rebate proposal
Sanofi, Johnson & Johnson, Eli Lilly and Bristol Myers Squibb have each filed complaints after facing federal opposition to their 340B rebate proposals.
Vaccines: Off-Label Use
A guide to the off-label use of vaccines, including deciding when to use vaccines off label, and managing patient concerns
Time to reframe the disease staging system for type 1 diabetes
In 2015, introduction of a disease staging system offered a framework for benchmarking progression to clinical type 1 diabetes. This model, based on islet autoantibodies…
The University of Hong Kong brings mobile dental AI to communities
The project specifically targets oral health issues among the elderly.
Home Page
The latest global news and analysis in payments, retail, fintech, financial services and the digital economy.
Eli Lilly’s Alzheimer’s treatment approved in China
China’s medical regulator has approved Eli Lilly’s treatment for early Alzheimer’s, providing patients with another option after Eisai and Biogen’s Leqembi received approval in January,…
